HYPE: “Zinc carnosine heals your gut lining and fixes leaky gut.”
But what does the evidence actually show?
Zinc L-carnosine has interesting evidence for protecting gastrointestinal mucosa in specific settings, including gastric-ulcer treatment and small experimental studies of intestinal permeability. That does not establish that a consumer supplement repairs the entire gut or cures a general condition called “leaky gut.”
Why People Believe It
Zinc L-carnosine is a complex of zinc and the small molecule carnosine; the therapeutic compound is also called polaprezinc. It has been used as a gastric-ulcer medicine in Japan and South Korea. That clinical history gives the claim a real foundation.
Laboratory work suggests effects on oxidative stress, protective proteins, cell repair and connections between cells. These mechanisms are plausible. A mechanism still needs human evidence showing the relevant benefit, with the relevant formulation, in the relevant people.
What the Evidence Shows
Evidence about the stomach is not evidence about every gut complaint
A trial across ten Chinese centres included 224 people with gastric ulcers and compared polaprezinc with rebamipide, another mucosal-protection medicine, over eight weeks. Both groups improved; the difference in the main gastroscopy-based effectiveness result was not statistically significant.
This supports taking the compound seriously in a defined therapeutic setting. An active-comparator trial without a clear between-group difference does not establish superiority or automatically prove equivalence. It also does not test a general wellness supplement in people with unexplained bloating or “leaky gut.”
Read the research ↗Protection against a specific induced barrier disturbance
In a small study, ten healthy volunteers took zinc carnosine or placebo during a short course of indomethacin, an anti-inflammatory medicine that can disturb the intestinal barrier. Zinc carnosine limited the increase in permeability measured using a urine sugar-ratio test.
The experiment used 37.5 mg twice daily for five days. That describes the research, not a recommended supplement dose. The study measured a barrier marker under an induced stressor; it did not establish lasting symptom relief or healing of a diagnosed chronic intestinal disease.
Read the research ↗A promising signal in eight volunteers
Eight volunteers completed a placebo-controlled crossover study involving zinc carnosine, bovine colostrum, their combination and placebo. After 14 days, zinc carnosine reduced the exercise-induced rise in a permeability marker; the combination showed additional effects.
Eight people under a strenuous exercise protocol cannot establish a general gut-healing claim. Associated cell experiments help explore mechanism, but they are not additional clinical trials. A change in a laboratory marker is not the same as better daily symptoms or prevention of disease.
Read the research ↗An adjunct to ulcer-related infection treatment
A review of three randomised trials involving 396 participants found better Helicobacter pylori eradication rates when polaprezinc was added to an antibiotic-and-acid-suppression regimen. This is evidence for an adjunct in a specific medical treatment, not zinc carnosine alone eliminating an infection.
The review authors described the evidence as scarce and called for larger trials. Antibiotic regimen, resistance patterns and clinical setting matter. It cannot establish that a supplement cures gastritis or general gastrointestinal symptoms without assessment and appropriate treatment.
Read the research ↗The formulation and safety dossier matter
EFSA assessed a submitted zinc L-carnosine novel-food material intended for supplements. It found insufficient characterisation, including unresolved particle and dissolution questions, and concluded that neither safety nor zinc bioavailability could be established from the data supplied.
That is a finding of insufficient evidence for the specific application, not proof that all zinc-carnosine products are harmful or a universal legal status. It does mean that therapeutic history should not be treated as automatic validation of every supplement formulation.
Read the research ↗The strongest evidence is therefore condition- and outcome-specific. Gastric protection, experimental intestinal permeability, broader inflammation and everyday gastrointestinal symptoms are related topics, but they cannot be merged into one established promise.
The Catch
The stomach and intestine are not interchangeable. Gastric mucosa is the stomach’s protective surface. The intestinal barrier controls passage across intestinal tissue. Evidence for one location or type of injury needs its own justification before being applied to another.
Increased intestinal permeability is a measurable phenomenon in particular circumstances. “Leaky gut,” as used online, is not a single universally defined diagnosis that explains all fatigue, bloating, food reactions or abdominal discomfort. A vague label cannot make a broadly marketed cure testable.
Human barrier studies are very small and short. Larger, independent trials measuring meaningful symptoms, disease outcomes and long-term safety are needed. Much of the therapeutic research concerns clinical use in East Asian settings; the location does not invalidate it, but treatment context, comparator, formulation and replication affect how far it travels.
The 2007 permeability paper includes a Lonza-affiliated author. That affiliation does not invalidate the finding, but it reinforces the value of independent replication. Manufacturer involvement, supplied products and disclosed interests deserve attention when interpreting supplement research. Neither a positive small experiment nor a reassuring short-term adverse-event count resolves all risks or confirms an independent, reproducible benefit.
Compound weight is not elemental zinc content. Total zinc from multiple products matters: excess zinc can cause nausea and, over time, copper deficiency. Zinc can interact with some medicines, including certain antibiotics. “Natural” does not answer dose, interaction or formulation questions.
What This Means for You
Persistent gastrointestinal symptoms deserve an appropriate assessment, rather than assuming that the lining needs a particular supplement. Zinc carnosine should not replace investigation or established treatment for an ulcer or another gastrointestinal condition.
If you are considering it, ask a pharmacist or clinician about the product, total elemental zinc and medicine interactions. The small studies discussed here are not a reason to self-prescribe a therapeutic regimen, particularly during pregnancy or when managing a medical condition.
Interesting evidence for specific mucosal effects. A much broader promise to “heal your gut” remains unproven.
Research & Sources
Gastric-ulcer trial (2022)
Efficacy and safety of polaprezinc in the treatment of gastric ulcer: A multicenter, randomized, double-blind, double-dummy, positive-controlled clinical trial
Primary clinical trial record
Original source ↗Mahmood et al. (2007)
Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes
Gut
Original source ↗Davison et al. (2016)
Zinc carnosine works with bovine colostrum in truncating heavy exercise-induced increase in gut permeability in healthy volunteers
American Journal of Clinical Nutrition 104:526–536
Original source ↗Mahmoud et al. (2022)
Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients 14:4126
Original source ↗EFSA NDA Panel (2026)
Safety of zinc L-carnosine as a novel food and bioavailability of zinc from this source
EFSA Journal 24:e10144
Original source ↗NIH Office of Dietary Supplements
Zinc: Fact Sheet for Consumers
Safety and medicine interactions
Original source ↗Evidence reviewed: October 2026. This is an editorial investigation, not an exhaustive systematic review or personal medical advice. The featured artwork is conceptual illustration, not a study result. Evidence Ratings assess support for the specific claim described above.
Compare another gut-health claim: Does Oil of Oregano With Black Seed Oil Really Kill Infections, Heal Your Gut and Boost Immunity?